| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Liu,Zhu-Qi | Chairman | 1.55% | |
| Huang,Wen-Liang | Director | 0.78% | |
| AN JI BIOMEDICAL CO., LTD. | Director | 12.67% | |
| He,Shi-Jun | Director | 1.18% | |
| Center Laboratories, Inc. | Director | 11.92% | |
| Chen,Jin-Long | Independent Director | 0.00% | |
| Chen,Wen-Hou | Independent Director | 0.00% | |
| Lv,Hui-Min | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 177,924 | 933,813 | 758,391 |
| Operating cost | 50,901 | 273,773 | 273,637 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 127,023 | 660,040 | 484,754 |
| Unrealized profit (loss) on sales of goods | 0 | 44,383 | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 127,023 | 615,657 | 484,754 |
| Operating expenses | 60,583 | 194,465 | 147,022 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 66,440 | 421,192 | 337,732 |
| Non-operating income and expenses | 36,313 | 39,552 | 285,282 |
| Net profit (loss) before tax | 102,753 | 460,744 | 623,014 |
| Income tax expense (benefits) | 14,191 | 93,493 | 83,617 |
| Net profit (loss) of ongoing business for the current period | 88,562 | 367,251 | 539,397 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 88,562 | 367,251 | 539,397 |
| Other comprehensive profit (loss), net | 675 | 1,599 | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 89,237 | 368,850 | 539,397 |
| Net profit (loss) attributable to owners of parent company | 88,562 | 367,251 | 539,397 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 89,237 | 368,850 | 539,397 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 1 | 4 | 7 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 228,532 | 440,336 | 421,740 |
| Net cash inflows (outflows) from investing activities | 146,729 | -23,463 | 61,599 |
| Net cash inflow (outflow) from financing activities | -323,747 | -451,638 | -500,471 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | 51,514 | -34,765 | -17,132 |
| Beginning balance of cash and cash equivalents | 301,675 | 336,440 | 353,572 |
| Ending balance of cash and cash equivalents | 353,189 | 301,675 | 336,440 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 1,021,677 | 1,223,248 | 1,520,867 |
| Non-current asset | 1,012,154 | 912,848 | 555,053 |
| Total asset | 2,033,831 | 2,136,096 | 2,075,920 |
| Current liability | 816,340 | 329,087 | 231,640 |
| Non-current liability | 65,013 | 12,730 | 1,319 |
| Total liability | 881,353 | 341,817 | 232,959 |
| share capital | 815,606 | 806,726 | 733,387 |
| Equity - secruity token | - | - | - |
| capital reserve | 599,810 | 551,722 | 785,907 |
| retained earning | 196,551 | 434,232 | 323,667 |
| Other equity | -120,655 | 1,599 | - |
| Treasury stock | -338,834 | 0 | 0 |
| Total equity attributable to owners of parent company | 1,152,478 | 1,794,279 | 1,842,961 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 1,152,478 | 1,794,279 | 1,842,961 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 1,858,000 | 0 | 0 |
| Net asset value per share | 14 | 22 | 25 |
